Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin?
- 30 June 2000
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 35 (7), 1699-1712
- https://doi.org/10.1016/s0735-1097(00)00648-3
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Hotline sessions of the 21st European Congress of CardiologyEuropean Heart Journal, 1999
- Low-Molecular-Weight HeparinCirculation, 1998
- Early Increase of von Willebrand Factor Predicts Adverse Outcome in Unstable Coronary Artery DiseaseCirculation, 1998
- Low-Molecular-Weight HeparinsCirculation, 1998
- Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin InhibitorCirculation, 1998
- Low-Molecular-Weight HeparinsThe New England Journal of Medicine, 1997
- Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic PlaquesCirculation, 1997
- Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemiaJournal of the American College of Cardiology, 1995
- The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparinBlood Coagulation & Fibrinolysis, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinThe New England Journal of Medicine, 1995